UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 29, 2015

 

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35547   36-4392754

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654

(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (312) 506-1200

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

At the 2015 Annual Meeting, the stockholders of the Company voted on the following four proposals and cast their votes as described below:

1. The individuals listed below were elected at the 2015 Annual Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified.

 

     For      Against      Abstain      Broker Non-Vote  

Stuart L. Bascomb

      157,567,044         764,184         95,762         13,049,160   

Paul M. Black

      157,605,893         738,120         82,977         13,049,160   

Dennis H. Chookaszian

      153,972,240         4,339,952         114,798         13,049,160   

Michael A. Klayko

      156,699,886         1,630,892         96,212         13,049,160   

Anita V. Pramoda

      157,128,959         1,220,885         77,146         13,049,160   

David D. Stevens

      157,543,868         799,829         83,293         13,049,160   

Ralph H. Thurman

      156,669,073         1,675,054         82,863         13,049,160   

2. A management proposal to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015, as described in the proxy materials, was approved.

 

For   Against   Abstain   Broker Non-Vote
171,354,562   51,477   70,111   0

3. A non-binding, advisory resolution to approve named executive compensation, as described in the proxy materials, was approved.

 

For   Against   Abstain   Broker Non-Vote
150,398,004   7,901,652   127,334   13,049,160

4. A management proposal to approve the amendment and restatement of the Company’s Fourth Amended and Restated Certificate of Incorporation, as described in the proxy materials, was approved.

 

For   Against   Abstain   Broker Non-Vote
158,195,130   145,086   86,774   13,049,160

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Date: June 1, 2015
By:

/s/ Brian P. Farley

Brian P. Farley

SVP, General Counsel and Corporate Secretary

Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Veradigm Charts.
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Veradigm Charts.